Dr. Prantesh Jain to present late-breaking findings from multicenter clinical trial of JNJ-86974680 Tuesday at AACR 2025. The results show that this investigational drug demonstrates activity in anti-PD1-resistant lung cancer and that targeting adenosine may enhance the effectiveness of...
↧